ENANTA PHARMACEUTICALS, INC (ENTA) Net income 2017–2026
ENANTA PHARMACEUTICALS, INC (ENTA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$81.9MFY2026 · since FY2017: $21.7M → -$81.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$81.9M | +29.4% |
| FY2025 | -$116.0M | +13.3% |
| FY2024 | -$133.8M | -9.9% |
| FY2023 | -$121.8M | -54.1% |
| FY2022 | -$79.0M | -118.4% |
| FY2021 | -$36.2M | -178.0% |
| FY2020 | $46.4M | -35.5% |
| FY2019 | $72.0M | +306.3% |
| FY2018 | $17.7M | -18.3% |
| FY2017 | $21.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice